Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXM1
|
ENSG00000111206.8 | forkhead box M1 |
TBL1XR1
|
ENSG00000177565.11 | TBL1X receptor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_2984763_2984914 | FOXM1 | 1269 | 0.251648 | 0.08 | 8.3e-01 | Click! |
chr12_2985350_2985997 | FOXM1 | 434 | 0.550895 | -0.02 | 9.7e-01 | Click! |
chr3_177035467_177035618 | TBL1XR1 | 120281 | 0.061155 | 0.84 | 4.8e-03 | Click! |
chr3_177017958_177018109 | TBL1XR1 | 102772 | 0.077535 | -0.84 | 5.0e-03 | Click! |
chr3_176892751_176892974 | TBL1XR1 | 21349 | 0.213345 | 0.82 | 7.1e-03 | Click! |
chr3_176893040_176893191 | TBL1XR1 | 21096 | 0.214280 | 0.80 | 8.9e-03 | Click! |
chr3_176941922_176942081 | TBL1XR1 | 26740 | 0.236464 | 0.79 | 1.1e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_198172189_198172384 | 4.97 |
ANKRD44 |
ankyrin repeat domain 44 |
3225 |
0.2 |
chr6_510010_510533 | 4.93 |
RP1-20B11.2 |
|
13900 |
0.28 |
chr1_101394971_101395556 | 4.91 |
SLC30A7 |
solute carrier family 30 (zinc transporter), member 7 |
32121 |
0.12 |
chr2_55757616_55757885 | 4.76 |
CCDC104 |
coiled-coil domain containing 104 |
10883 |
0.15 |
chr6_235548_235774 | 4.41 |
DUSP22 |
dual specificity phosphatase 22 |
55969 |
0.17 |
chr7_142420927_142421220 | 4.35 |
PRSS1 |
protease, serine, 1 (trypsin 1) |
36246 |
0.15 |
chr15_22460371_22460742 | 4.33 |
AC010760.1 |
|
3661 |
0.15 |
chr1_172673559_172674098 | 4.29 |
FASLG |
Fas ligand (TNF superfamily, member 6) |
45670 |
0.18 |
chr1_169670629_169671082 | 4.06 |
SELL |
selectin L |
9984 |
0.2 |
chr18_60883221_60883629 | 4.02 |
ENSG00000238988 |
. |
21527 |
0.2 |
chr7_55535980_55536327 | 4.01 |
VOPP1 |
vesicular, overexpressed in cancer, prosurvival protein 1 |
47617 |
0.16 |
chr17_46514333_46514598 | 4.00 |
SKAP1 |
src kinase associated phosphoprotein 1 |
6884 |
0.15 |
chr15_86188672_86188945 | 3.99 |
AKAP13 |
A kinase (PRKA) anchor protein 13 |
342 |
0.83 |
chr5_75818692_75818927 | 3.99 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
24425 |
0.22 |
chr21_19186267_19186567 | 3.97 |
C21orf91 |
chromosome 21 open reading frame 91 |
4919 |
0.23 |
chr1_65342372_65342702 | 3.96 |
JAK1 |
Janus kinase 1 |
89650 |
0.08 |
chr7_38348883_38349236 | 3.91 |
STARD3NL |
STARD3 N-terminal like |
131062 |
0.05 |
chr1_32825174_32825467 | 3.90 |
FAM229A |
family with sequence similarity 229, member A |
2105 |
0.2 |
chr4_39028874_39029217 | 3.90 |
TMEM156 |
transmembrane protein 156 |
4996 |
0.23 |
chr12_92579451_92579773 | 3.88 |
ENSG00000199895 |
. |
15383 |
0.19 |
chr11_118097693_118098499 | 3.86 |
AMICA1 |
adhesion molecule, interacts with CXADR antigen 1 |
2287 |
0.23 |
chr3_46017069_46017657 | 3.85 |
FYCO1 |
FYVE and coiled-coil domain containing 1 |
9124 |
0.18 |
chr1_100876837_100877178 | 3.81 |
ENSG00000216067 |
. |
32676 |
0.16 |
chr12_54358179_54358462 | 3.80 |
HOTAIR |
HOX transcript antisense RNA |
2094 |
0.12 |
chr9_100866822_100867164 | 3.77 |
TRIM14 |
tripartite motif containing 14 |
12150 |
0.18 |
chr3_151964839_151965075 | 3.77 |
MBNL1 |
muscleblind-like splicing regulator 1 |
20872 |
0.21 |
chr4_184352478_184352629 | 3.75 |
CDKN2AIP |
CDKN2A interacting protein |
13191 |
0.18 |
chr5_169706707_169706999 | 3.75 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
12522 |
0.22 |
chr17_14101706_14102107 | 3.74 |
AC005224.2 |
|
11899 |
0.2 |
chr7_50303470_50303901 | 3.73 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
40639 |
0.19 |
chr16_79313034_79313388 | 3.73 |
ENSG00000222244 |
. |
14860 |
0.29 |
chr6_24955515_24955958 | 3.73 |
FAM65B |
family with sequence similarity 65, member B |
19548 |
0.21 |
chr6_99938862_99939169 | 3.72 |
USP45 |
ubiquitin specific peptidase 45 |
8274 |
0.18 |
chr1_169659993_169660655 | 3.71 |
SELL |
selectin L |
20515 |
0.18 |
chr16_79312025_79312573 | 3.70 |
ENSG00000222244 |
. |
13948 |
0.29 |
chr20_2722949_2723333 | 3.70 |
EBF4 |
early B-cell factor 4 |
36254 |
0.09 |
chr9_123922402_123922553 | 3.70 |
CNTRL |
centriolin |
2356 |
0.28 |
chr11_35351604_35352020 | 3.69 |
SLC1A2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
28737 |
0.17 |
chr2_204810952_204811163 | 3.68 |
ICOS |
inducible T-cell co-stimulator |
9554 |
0.28 |
chr1_156494924_156495366 | 3.68 |
ENSG00000238843 |
. |
3977 |
0.14 |
chr22_40296066_40296492 | 3.66 |
GRAP2 |
GRB2-related adaptor protein 2 |
807 |
0.6 |
chr5_75627353_75627826 | 3.66 |
RP11-466P24.6 |
|
20302 |
0.25 |
chr8_33411554_33412290 | 3.66 |
RNF122 |
ring finger protein 122 |
12721 |
0.13 |
chr1_111433191_111433378 | 3.65 |
CD53 |
CD53 molecule |
17508 |
0.17 |
chr5_14983835_14984240 | 3.64 |
ENSG00000212036 |
. |
73288 |
0.11 |
chr3_186756396_186756829 | 3.61 |
ST6GAL1 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
4919 |
0.27 |
chr1_92782260_92782485 | 3.60 |
GLMN |
glomulin, FKBP associated protein |
17828 |
0.18 |
chr7_38262255_38262771 | 3.58 |
STARD3NL |
STARD3 N-terminal like |
44516 |
0.2 |
chr1_117283826_117284150 | 3.56 |
CD2 |
CD2 molecule |
13019 |
0.2 |
chr22_40719905_40720423 | 3.55 |
ADSL |
adenylosuccinate lyase |
22343 |
0.17 |
chrX_20229682_20229905 | 3.54 |
RPS6KA3 |
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
7186 |
0.22 |
chr22_40329879_40330140 | 3.54 |
GRAP2 |
GRB2-related adaptor protein 2 |
7368 |
0.18 |
chr11_122958905_122959288 | 3.54 |
HSPA8 |
heat shock 70kDa protein 8 |
25158 |
0.13 |
chr7_8019452_8019603 | 3.54 |
AC006042.7 |
|
9993 |
0.18 |
chr1_101587391_101587816 | 3.53 |
ENSG00000252765 |
. |
11106 |
0.2 |
chr7_3078977_3079128 | 3.52 |
CARD11 |
caspase recruitment domain family, member 11 |
4427 |
0.27 |
chr12_21831996_21832380 | 3.51 |
RP11-59N23.3 |
|
16941 |
0.18 |
chr3_195179662_195179898 | 3.51 |
ACAP2 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 |
15973 |
0.18 |
chr10_14569816_14570147 | 3.50 |
FAM107B |
family with sequence similarity 107, member B |
4728 |
0.27 |
chr5_39211100_39211451 | 3.50 |
FYB |
FYN binding protein |
8146 |
0.29 |
chr5_36724502_36724744 | 3.48 |
CTD-2353F22.1 |
|
652 |
0.82 |
chr12_122585637_122585916 | 3.47 |
MLXIP |
MLX interacting protein |
26651 |
0.17 |
chr5_110568093_110568590 | 3.47 |
CAMK4 |
calcium/calmodulin-dependent protein kinase IV |
8557 |
0.23 |
chr1_169672251_169672700 | 3.46 |
SELL |
selectin L |
8364 |
0.2 |
chr2_143975432_143975856 | 3.46 |
RP11-190J23.1 |
|
45903 |
0.18 |
chr18_3059865_3060090 | 3.46 |
ENSG00000252353 |
. |
33589 |
0.13 |
chr1_65329902_65330534 | 3.46 |
RAVER2 |
ribonucleoprotein, PTB-binding 2 |
86471 |
0.09 |
chr5_75766935_75767521 | 3.45 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
66979 |
0.12 |
chr7_150373343_150373718 | 3.45 |
GIMAP2 |
GTPase, IMAP family member 2 |
9258 |
0.17 |
chr14_97875302_97875453 | 3.45 |
ENSG00000240730 |
. |
121133 |
0.07 |
chr6_11381306_11381671 | 3.44 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
1044 |
0.66 |
chr5_55391333_55391775 | 3.44 |
ANKRD55 |
ankyrin repeat domain 55 |
21224 |
0.16 |
chr15_64153064_64153315 | 3.44 |
ENSG00000199156 |
. |
10029 |
0.21 |
chr9_92031645_92032185 | 3.43 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
1833 |
0.43 |
chr2_198121682_198122119 | 3.42 |
ANKRD44-IT1 |
ANKRD44 intronic transcript 1 (non-protein coding) |
45343 |
0.12 |
chr7_105663734_105664425 | 3.41 |
CDHR3 |
cadherin-related family member 3 |
8509 |
0.28 |
chr2_182089447_182089783 | 3.40 |
ENSG00000266705 |
. |
80764 |
0.11 |
chr1_12405936_12406365 | 3.39 |
VPS13D |
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
63774 |
0.11 |
chr7_50360747_50361062 | 3.39 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
6341 |
0.3 |
chr12_111043558_111043709 | 3.37 |
TCTN1 |
tectonic family member 1 |
8199 |
0.15 |
chr15_91116760_91116911 | 3.37 |
CRTC3 |
CREB regulated transcription coactivator 3 |
20110 |
0.15 |
chr13_103255109_103255433 | 3.35 |
TPP2 |
tripeptidyl peptidase II |
5898 |
0.21 |
chr2_42523029_42523463 | 3.34 |
EML4 |
echinoderm microtubule associated protein like 4 |
5147 |
0.28 |
chr7_50420641_50421240 | 3.32 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
53695 |
0.14 |
chr1_169871479_169871750 | 3.31 |
SCYL3 |
SCY1-like 3 (S. cerevisiae) |
8206 |
0.2 |
chr16_3554214_3554503 | 3.31 |
CLUAP1 |
clusterin associated protein 1 |
2314 |
0.2 |
chr1_222596358_222596620 | 3.30 |
ENSG00000222399 |
. |
80588 |
0.1 |
chr6_35278431_35279308 | 3.30 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
1354 |
0.42 |
chr7_33097594_33097745 | 3.30 |
NT5C3A |
5'-nucleotidase, cytosolic IIIA |
4722 |
0.18 |
chr10_6114690_6114980 | 3.29 |
IL2RA |
interleukin 2 receptor, alpha |
10547 |
0.15 |
chr4_16218903_16219210 | 3.29 |
TAPT1 |
transmembrane anterior posterior transformation 1 |
9038 |
0.2 |
chr8_126941263_126941691 | 3.28 |
ENSG00000206695 |
. |
28282 |
0.26 |
chr3_56816249_56816696 | 3.27 |
ARHGEF3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
6787 |
0.3 |
chr4_122075686_122076066 | 3.27 |
TNIP3 |
TNFAIP3 interacting protein 3 |
9619 |
0.23 |
chr12_92949909_92950139 | 3.26 |
ENSG00000238865 |
. |
11261 |
0.26 |
chr10_17471175_17471536 | 3.26 |
ST8SIA6-AS1 |
ST8SIA6 antisense RNA 1 |
21329 |
0.17 |
chr13_113807025_113807176 | 3.25 |
PROZ |
protein Z, vitamin K-dependent plasma glycoprotein |
5868 |
0.13 |
chr17_48986753_48987319 | 3.25 |
TOB1 |
transducer of ERBB2, 1 |
41697 |
0.12 |
chr15_70849476_70849729 | 3.24 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
145018 |
0.05 |
chr18_2639989_2640349 | 3.23 |
ENSG00000200875 |
. |
9697 |
0.14 |
chr19_50431904_50432210 | 3.23 |
ATF5 |
activating transcription factor 5 |
98 |
0.81 |
chr4_90206694_90207088 | 3.23 |
GPRIN3 |
GPRIN family member 3 |
22270 |
0.27 |
chr17_80083513_80083920 | 3.22 |
CCDC57 |
coiled-coil domain containing 57 |
2716 |
0.14 |
chr8_8705832_8706014 | 3.21 |
MFHAS1 |
malignant fibrous histiocytoma amplified sequence 1 |
45232 |
0.14 |
chr5_137030816_137031463 | 3.21 |
KLHL3 |
kelch-like family member 3 |
10970 |
0.22 |
chr12_50908113_50908460 | 3.20 |
DIP2B |
DIP2 disco-interacting protein 2 homolog B (Drosophila) |
9396 |
0.23 |
chrX_70379151_70379501 | 3.20 |
NLGN3 |
neuroligin 3 |
14614 |
0.11 |
chr8_126941795_126942152 | 3.19 |
ENSG00000206695 |
. |
28778 |
0.26 |
chr3_43454550_43454809 | 3.19 |
ENSG00000251811 |
. |
59290 |
0.11 |
chr20_35286974_35287377 | 3.19 |
ENSG00000202255 |
. |
9898 |
0.14 |
chr7_37381820_37382186 | 3.18 |
ELMO1 |
engulfment and cell motility 1 |
364 |
0.89 |
chr10_22934487_22934638 | 3.18 |
PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
53920 |
0.16 |
chr1_161151441_161151597 | 3.17 |
B4GALT3 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3 |
4232 |
0.08 |
chr10_11257130_11257986 | 3.17 |
RP3-323N1.2 |
|
44219 |
0.16 |
chr2_61268638_61268902 | 3.17 |
PUS10 |
pseudouridylate synthase 10 |
23381 |
0.14 |
chr5_75686448_75686904 | 3.17 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
12398 |
0.27 |
chr3_59971570_59972142 | 3.16 |
NPCDR1 |
nasopharyngeal carcinoma, down-regulated 1 |
14273 |
0.32 |
chr11_117819899_117820198 | 3.16 |
TMPRSS13 |
transmembrane protease, serine 13 |
19874 |
0.16 |
chr13_51466079_51466258 | 3.16 |
RNASEH2B-AS1 |
RNASEH2B antisense RNA 1 |
390 |
0.86 |
chr1_205595237_205595704 | 3.16 |
ELK4 |
ELK4, ETS-domain protein (SRF accessory protein 1) |
5620 |
0.17 |
chr2_231227490_231227778 | 3.15 |
SP140L |
SP140 nuclear body protein-like |
20849 |
0.21 |
chr9_88953538_88953925 | 3.15 |
ZCCHC6 |
zinc finger, CCHC domain containing 6 |
4307 |
0.27 |
chr15_90849576_90849930 | 3.15 |
ENSG00000221309 |
. |
11480 |
0.12 |
chr3_36942506_36942657 | 3.14 |
TRANK1 |
tetratricopeptide repeat and ankyrin repeat containing 1 |
42207 |
0.15 |
chr5_93912907_93913170 | 3.14 |
ENSG00000211498 |
. |
1436 |
0.44 |
chr8_133990678_133991177 | 3.12 |
TG |
thyroglobulin |
14075 |
0.25 |
chr8_61693757_61693981 | 3.12 |
RP11-33I11.2 |
|
28296 |
0.21 |
chr1_154386186_154386337 | 3.12 |
RP11-350G8.5 |
|
7221 |
0.13 |
chr10_8280708_8281544 | 3.11 |
GATA3 |
GATA binding protein 3 |
184357 |
0.03 |
chr2_85066895_85067327 | 3.09 |
TRABD2A |
TraB domain containing 2A |
41095 |
0.14 |
chr14_70094942_70095452 | 3.08 |
KIAA0247 |
KIAA0247 |
16884 |
0.22 |
chr1_167434236_167434536 | 3.08 |
RP11-104L21.2 |
|
6488 |
0.23 |
chr4_154038224_154038415 | 3.08 |
TRIM2 |
tripartite motif containing 2 |
35326 |
0.2 |
chr17_19031223_19031685 | 3.08 |
GRAPL |
GRB2-related adaptor protein-like |
606 |
0.53 |
chr1_227505333_227505687 | 3.08 |
CDC42BPA |
CDC42 binding protein kinase alpha (DMPK-like) |
95 |
0.98 |
chr8_22388694_22388952 | 3.08 |
RP11-582J16.4 |
|
14095 |
0.11 |
chr12_66685588_66685946 | 3.07 |
ENSG00000222744 |
. |
696 |
0.65 |
chr6_167534795_167535192 | 3.07 |
CCR6 |
chemokine (C-C motif) receptor 6 |
1264 |
0.46 |
chr1_211503644_211504001 | 3.06 |
TRAF5 |
TNF receptor-associated factor 5 |
3643 |
0.3 |
chr5_14559897_14560191 | 3.05 |
FAM105A |
family with sequence similarity 105, member A |
21840 |
0.23 |
chr12_92522561_92522842 | 3.04 |
C12orf79 |
chromosome 12 open reading frame 79 |
8096 |
0.19 |
chr9_132658123_132658578 | 3.04 |
FNBP1 |
formin binding protein 1 |
23239 |
0.15 |
chr4_109037043_109037432 | 3.04 |
LEF1 |
lymphoid enhancer-binding factor 1 |
50220 |
0.14 |
chr7_38397041_38397330 | 3.04 |
AMPH |
amphiphysin |
105528 |
0.08 |
chr16_69600802_69601252 | 3.03 |
NFAT5 |
nuclear factor of activated T-cells 5, tonicity-responsive |
773 |
0.53 |
chr2_42456939_42457352 | 3.02 |
AC083949.1 |
|
59704 |
0.12 |
chr10_112629194_112629460 | 3.02 |
PDCD4 |
programmed cell death 4 (neoplastic transformation inhibitor) |
2238 |
0.22 |
chr1_206747367_206748212 | 3.02 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
17296 |
0.15 |
chr2_204725673_204726054 | 3.02 |
CTLA4 |
cytotoxic T-lymphocyte-associated protein 4 |
6646 |
0.27 |
chr1_194022845_194023072 | 3.02 |
ENSG00000252241 |
. |
321884 |
0.01 |
chr3_105470057_105470437 | 3.02 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
49202 |
0.2 |
chr12_96493641_96494042 | 3.02 |
ENSG00000266889 |
. |
2186 |
0.32 |
chr10_6087785_6087989 | 3.02 |
IL2RA |
interleukin 2 receptor, alpha |
16366 |
0.13 |
chr12_57874491_57874847 | 3.02 |
ARHGAP9 |
Rho GTPase activating protein 9 |
1020 |
0.29 |
chr2_204586779_204587049 | 3.01 |
CD28 |
CD28 molecule |
15498 |
0.22 |
chr3_42214622_42214860 | 3.00 |
TRAK1 |
trafficking protein, kinesin binding 1 |
13080 |
0.23 |
chr2_127421401_127421701 | 3.00 |
GYPC |
glycophorin C (Gerbich blood group) |
7791 |
0.28 |
chr15_86162444_86162761 | 3.00 |
RP11-815J21.3 |
|
8318 |
0.15 |
chr19_41808919_41809299 | 2.98 |
CCDC97 |
coiled-coil domain containing 97 |
6985 |
0.11 |
chr10_69372353_69372580 | 2.98 |
CTNNA3 |
catenin (cadherin-associated protein), alpha 3 |
34805 |
0.23 |
chr12_58175242_58176026 | 2.96 |
TSFM |
Ts translation elongation factor, mitochondrial |
738 |
0.36 |
chr17_29646548_29646789 | 2.96 |
CTD-2370N5.3 |
|
819 |
0.44 |
chr11_128336531_128336741 | 2.96 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
38653 |
0.19 |
chr16_50196494_50196816 | 2.96 |
PAPD5 |
PAP associated domain containing 5 |
8876 |
0.16 |
chr6_35643827_35643978 | 2.96 |
ENSG00000265527 |
. |
11336 |
0.13 |
chr3_108550085_108550421 | 2.96 |
TRAT1 |
T cell receptor associated transmembrane adaptor 1 |
8634 |
0.27 |
chr2_136809392_136809630 | 2.96 |
AC093391.2 |
|
39476 |
0.17 |
chr8_19372813_19373265 | 2.95 |
CSGALNACT1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
86337 |
0.1 |
chr5_79031857_79032248 | 2.95 |
CMYA5 |
cardiomyopathy associated 5 |
46352 |
0.16 |
chr2_197996623_197996912 | 2.95 |
ANKRD44 |
ankyrin repeat domain 44 |
9310 |
0.26 |
chr10_115721889_115722163 | 2.95 |
AL162407.1 |
CDNA FLJ20147 fis, clone COL07954; HCG1781466; Uncharacterized protein |
47496 |
0.14 |
chr2_162057078_162057353 | 2.94 |
TANK |
TRAF family member-associated NFKB activator |
21083 |
0.19 |
chr12_56496025_56496345 | 2.94 |
RP11-603J24.9 |
Uncharacterized protein |
1070 |
0.22 |
chrX_15775832_15776200 | 2.93 |
CA5B |
carbonic anhydrase VB, mitochondrial |
7923 |
0.19 |
chr15_81587451_81588017 | 2.92 |
IL16 |
interleukin 16 |
1520 |
0.42 |
chr7_50304029_50304431 | 2.92 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
40094 |
0.19 |
chr22_23165498_23166442 | 2.92 |
ENSG00000207836 |
. |
700 |
0.26 |
chr5_110589229_110589463 | 2.91 |
AC010468.2 |
|
16441 |
0.2 |
chr17_74188563_74188915 | 2.91 |
RNF157 |
ring finger protein 157 |
25576 |
0.11 |
chr7_99272531_99272996 | 2.90 |
CYP3A5 |
cytochrome P450, family 3, subfamily A, polypeptide 5 |
4853 |
0.17 |
chr5_145585619_145585871 | 2.90 |
RBM27 |
RNA binding motif protein 27 |
2582 |
0.28 |
chr4_71603069_71603418 | 2.90 |
RUFY3 |
RUN and FYVE domain containing 3 |
3092 |
0.18 |
chr10_11193217_11193852 | 2.89 |
CELF2 |
CUGBP, Elav-like family member 2 |
13459 |
0.2 |
chr2_191380520_191380777 | 2.89 |
TMEM194B |
transmembrane protein 194B |
18435 |
0.15 |
chr7_50431752_50432472 | 2.88 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
64867 |
0.11 |
chr9_110076023_110076195 | 2.88 |
RAD23B |
RAD23 homolog B (S. cerevisiae) |
7286 |
0.3 |
chr7_142504052_142504347 | 2.88 |
PRSS3P2 |
protease, serine, 3 pseudogene 2 |
23068 |
0.15 |
chr11_128601887_128602059 | 2.88 |
FLI1 |
Fli-1 proto-oncogene, ETS transcription factor |
32712 |
0.15 |
chr5_138951385_138951635 | 2.88 |
UBE2D2 |
ubiquitin-conjugating enzyme E2D 2 |
9896 |
0.17 |
chr3_107697281_107697722 | 2.88 |
CD47 |
CD47 molecule |
79707 |
0.11 |
chr12_8143509_8143796 | 2.87 |
ENSG00000206636 |
. |
14797 |
0.15 |
chr12_4082991_4083686 | 2.87 |
RP11-664D1.1 |
|
68952 |
0.12 |
chr2_112286879_112287398 | 2.87 |
ENSG00000266139 |
. |
208470 |
0.02 |
chr11_118177987_118178215 | 2.87 |
CD3E |
CD3e molecule, epsilon (CD3-TCR complex) |
2487 |
0.19 |
chr2_225806071_225806268 | 2.86 |
DOCK10 |
dedicator of cytokinesis 10 |
5613 |
0.32 |
chr16_27383842_27384241 | 2.86 |
IL4R |
interleukin 4 receptor |
20045 |
0.18 |
chr1_114334112_114334428 | 2.86 |
RP5-1073O3.2 |
|
20731 |
0.14 |
chr17_37252182_37252943 | 2.85 |
PLXDC1 |
plexin domain containing 1 |
11178 |
0.15 |
chrX_70839652_70840082 | 2.85 |
CXCR3 |
chemokine (C-X-C motif) receptor 3 |
1500 |
0.39 |
chr19_50064241_50064618 | 2.84 |
NOSIP |
nitric oxide synthase interacting protein |
481 |
0.57 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.5 | 34.0 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
8.3 | 33.3 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
7.7 | 7.7 | GO:0002326 | B cell lineage commitment(GO:0002326) |
7.3 | 29.2 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
7.2 | 28.8 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
6.0 | 24.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
5.7 | 17.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
5.7 | 17.0 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
5.6 | 5.6 | GO:0002517 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
5.2 | 10.4 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
5.0 | 15.1 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
5.0 | 15.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
4.4 | 13.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
4.4 | 13.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
4.3 | 30.1 | GO:0007172 | signal complex assembly(GO:0007172) |
4.2 | 12.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
4.2 | 8.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
4.0 | 11.9 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
3.8 | 11.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
3.7 | 11.2 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
3.6 | 28.6 | GO:0006491 | N-glycan processing(GO:0006491) |
3.5 | 24.3 | GO:0002834 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
3.4 | 27.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
3.4 | 10.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
3.4 | 16.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
3.4 | 6.7 | GO:0030223 | neutrophil differentiation(GO:0030223) |
3.2 | 9.7 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
3.2 | 3.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
3.2 | 31.7 | GO:0043368 | positive T cell selection(GO:0043368) |
3.2 | 6.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
3.0 | 78.4 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
3.0 | 12.0 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
3.0 | 5.9 | GO:0002707 | negative regulation of lymphocyte mediated immunity(GO:0002707) |
2.9 | 14.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
2.9 | 8.8 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
2.9 | 2.9 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) sodium ion homeostasis(GO:0055078) |
2.8 | 8.5 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
2.8 | 14.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
2.7 | 10.9 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
2.7 | 5.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
2.6 | 2.6 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
2.6 | 5.2 | GO:0006154 | adenosine catabolic process(GO:0006154) |
2.6 | 7.8 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
2.6 | 2.6 | GO:0002335 | mature B cell differentiation(GO:0002335) |
2.6 | 12.8 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
2.6 | 5.1 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
2.5 | 5.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
2.5 | 7.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
2.5 | 12.6 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
2.5 | 17.6 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
2.5 | 10.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
2.4 | 2.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
2.4 | 7.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
2.4 | 12.2 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
2.4 | 7.3 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
2.4 | 7.3 | GO:0006089 | lactate metabolic process(GO:0006089) |
2.4 | 7.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
2.4 | 12.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
2.4 | 23.9 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
2.3 | 7.0 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
2.3 | 28.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
2.3 | 4.6 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
2.3 | 20.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
2.3 | 6.9 | GO:0002507 | tolerance induction(GO:0002507) |
2.2 | 2.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
2.2 | 6.6 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
2.2 | 6.5 | GO:0070602 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
2.2 | 8.6 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
2.1 | 10.6 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
2.1 | 8.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
2.1 | 2.1 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
2.1 | 8.3 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
2.0 | 6.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
2.0 | 4.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
2.0 | 16.2 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
2.0 | 4.1 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
2.0 | 2.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
2.0 | 10.0 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
2.0 | 6.0 | GO:0045056 | transcytosis(GO:0045056) |
2.0 | 5.9 | GO:0015917 | aminophospholipid transport(GO:0015917) |
1.9 | 7.8 | GO:0022614 | membrane to membrane docking(GO:0022614) |
1.9 | 1.9 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
1.9 | 11.4 | GO:0032733 | regulation of interleukin-10 production(GO:0032653) positive regulation of interleukin-10 production(GO:0032733) |
1.9 | 5.7 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
1.9 | 1.9 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
1.9 | 99.5 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
1.9 | 5.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.9 | 9.4 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
1.8 | 5.5 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
1.8 | 1.8 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
1.8 | 19.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
1.7 | 7.0 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
1.7 | 8.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.7 | 5.2 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
1.7 | 1.7 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
1.7 | 10.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
1.7 | 6.8 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
1.7 | 5.0 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
1.7 | 23.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
1.6 | 3.3 | GO:0034776 | response to histamine(GO:0034776) |
1.6 | 3.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
1.6 | 1.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
1.6 | 1.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.6 | 1.6 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
1.6 | 4.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.6 | 4.7 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
1.6 | 6.2 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
1.6 | 6.2 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
1.5 | 9.3 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
1.5 | 4.6 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
1.5 | 4.6 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
1.5 | 16.9 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
1.5 | 6.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
1.5 | 10.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
1.5 | 6.0 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
1.5 | 1.5 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
1.5 | 6.0 | GO:0070670 | response to interleukin-4(GO:0070670) |
1.5 | 3.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
1.5 | 4.5 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
1.5 | 4.4 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
1.5 | 3.0 | GO:0046398 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
1.5 | 7.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
1.5 | 2.9 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.5 | 1.5 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
1.5 | 2.9 | GO:0017085 | response to insecticide(GO:0017085) |
1.5 | 2.9 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
1.5 | 4.4 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
1.5 | 10.2 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
1.5 | 5.8 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
1.4 | 21.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
1.4 | 2.9 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
1.4 | 1.4 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
1.4 | 1.4 | GO:0071801 | regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) |
1.4 | 8.5 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.4 | 4.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
1.4 | 4.2 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.4 | 1.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.4 | 7.0 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
1.4 | 34.8 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
1.4 | 2.8 | GO:0042511 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
1.4 | 4.2 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
1.4 | 9.6 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
1.4 | 11.0 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
1.4 | 1.4 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
1.4 | 5.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
1.3 | 6.7 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
1.3 | 2.7 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
1.3 | 6.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.3 | 2.6 | GO:0010761 | fibroblast migration(GO:0010761) |
1.3 | 17.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
1.3 | 2.6 | GO:0002418 | immune response to tumor cell(GO:0002418) |
1.3 | 1.3 | GO:0006323 | DNA packaging(GO:0006323) |
1.3 | 1.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
1.3 | 3.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
1.3 | 11.7 | GO:0032456 | endocytic recycling(GO:0032456) |
1.3 | 22.0 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
1.3 | 1.3 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
1.3 | 2.6 | GO:0001562 | response to protozoan(GO:0001562) |
1.3 | 1.3 | GO:0019730 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
1.3 | 6.3 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
1.3 | 3.8 | GO:0021570 | rhombomere 4 development(GO:0021570) |
1.3 | 3.8 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
1.3 | 5.0 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
1.3 | 6.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
1.3 | 5.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.2 | 6.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
1.2 | 18.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
1.2 | 3.7 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
1.2 | 3.7 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
1.2 | 3.7 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
1.2 | 12.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
1.2 | 3.6 | GO:0032506 | cytokinetic process(GO:0032506) |
1.2 | 3.6 | GO:0048535 | lymph node development(GO:0048535) |
1.2 | 2.4 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
1.2 | 3.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.2 | 4.8 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.2 | 2.4 | GO:1902305 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
1.2 | 1.2 | GO:0007098 | centrosome cycle(GO:0007098) |
1.2 | 5.9 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
1.2 | 3.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
1.2 | 11.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
1.2 | 1.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
1.2 | 5.8 | GO:0016572 | histone phosphorylation(GO:0016572) |
1.2 | 2.3 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
1.2 | 5.8 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
1.2 | 1.2 | GO:0031223 | auditory behavior(GO:0031223) |
1.2 | 1.2 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
1.2 | 1.2 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
1.2 | 1.2 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
1.2 | 4.6 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
1.1 | 3.4 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
1.1 | 1.1 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
1.1 | 2.3 | GO:0034145 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) regulation of toll-like receptor 4 signaling pathway(GO:0034143) positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
1.1 | 3.4 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
1.1 | 9.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.1 | 2.2 | GO:0001821 | histamine secretion(GO:0001821) |
1.1 | 25.6 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
1.1 | 11.1 | GO:0031648 | protein destabilization(GO:0031648) |
1.1 | 1.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
1.1 | 2.2 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
1.1 | 11.0 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
1.1 | 3.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
1.1 | 19.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
1.1 | 2.2 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
1.1 | 2.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
1.1 | 3.2 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
1.1 | 2.1 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
1.0 | 4.2 | GO:0019228 | neuronal action potential(GO:0019228) |
1.0 | 2.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
1.0 | 4.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
1.0 | 13.5 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
1.0 | 1.0 | GO:0048478 | replication fork protection(GO:0048478) |
1.0 | 2.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.0 | 3.1 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
1.0 | 9.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
1.0 | 3.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
1.0 | 2.0 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
1.0 | 1.0 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
1.0 | 2.0 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
1.0 | 8.1 | GO:0015671 | oxygen transport(GO:0015671) |
1.0 | 3.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
1.0 | 1.0 | GO:0033483 | oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
1.0 | 2.0 | GO:0043393 | regulation of protein binding(GO:0043393) |
1.0 | 2.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.0 | 9.1 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
1.0 | 1.0 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
1.0 | 4.0 | GO:0030032 | lamellipodium assembly(GO:0030032) |
1.0 | 6.0 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
1.0 | 3.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
1.0 | 2.0 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
1.0 | 2.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
1.0 | 1.0 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
1.0 | 2.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.0 | 2.0 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
1.0 | 3.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.0 | 2.0 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
1.0 | 2.9 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
1.0 | 4.8 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
1.0 | 14.4 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
1.0 | 3.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.9 | 0.9 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.9 | 9.5 | GO:0000303 | response to superoxide(GO:0000303) |
0.9 | 2.8 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.9 | 0.9 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.9 | 0.9 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.9 | 2.8 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.9 | 1.9 | GO:0072239 | metanephric glomerulus development(GO:0072224) metanephric glomerulus vasculature development(GO:0072239) |
0.9 | 2.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.9 | 2.8 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.9 | 0.9 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.9 | 2.8 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.9 | 0.9 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.9 | 2.8 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.9 | 6.5 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.9 | 8.3 | GO:0045730 | respiratory burst(GO:0045730) |
0.9 | 1.8 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.9 | 0.9 | GO:0006997 | nucleus organization(GO:0006997) |
0.9 | 1.8 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.9 | 3.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.9 | 1.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.9 | 0.9 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.9 | 3.6 | GO:0051282 | release of sequestered calcium ion into cytosol(GO:0051209) regulation of sequestering of calcium ion(GO:0051282) negative regulation of sequestering of calcium ion(GO:0051283) calcium ion transmembrane import into cytosol(GO:0097553) calcium ion import into cytosol(GO:1902656) |
0.9 | 3.6 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.9 | 2.7 | GO:0010447 | response to acidic pH(GO:0010447) |
0.9 | 1.8 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.9 | 4.5 | GO:0021684 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.9 | 4.5 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.9 | 3.6 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
0.9 | 4.4 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.9 | 3.6 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.9 | 4.4 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.9 | 0.9 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.9 | 3.5 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.9 | 3.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.9 | 3.5 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.9 | 2.6 | GO:0051451 | myoblast migration(GO:0051451) |
0.9 | 2.6 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.9 | 6.1 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.9 | 1.7 | GO:0030449 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.9 | 5.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.9 | 0.9 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.9 | 4.3 | GO:0098930 | axonal transport(GO:0098930) |
0.9 | 18.0 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.9 | 1.7 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.8 | 2.5 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.8 | 3.4 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.8 | 1.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.8 | 0.8 | GO:0002688 | regulation of leukocyte chemotaxis(GO:0002688) |
0.8 | 0.8 | GO:0097300 | necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
0.8 | 18.6 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.8 | 3.4 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.8 | 5.0 | GO:1904377 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.8 | 0.8 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.8 | 4.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.8 | 1.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.8 | 1.7 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.8 | 21.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.8 | 1.6 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.8 | 0.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.8 | 3.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.8 | 3.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.8 | 4.8 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.8 | 0.8 | GO:1901072 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.8 | 2.4 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.8 | 1.6 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.8 | 0.8 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.8 | 3.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.8 | 4.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.8 | 2.4 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.8 | 1.6 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.8 | 7.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.8 | 2.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.8 | 11.8 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.8 | 5.5 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.8 | 4.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.8 | 0.8 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.8 | 2.3 | GO:1902579 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.8 | 61.3 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.8 | 0.8 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.8 | 1.6 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.8 | 3.9 | GO:0070489 | T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
0.8 | 3.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.8 | 5.4 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.8 | 0.8 | GO:0021561 | facial nerve development(GO:0021561) |
0.8 | 6.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.8 | 2.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.8 | 0.8 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.8 | 0.8 | GO:0003032 | detection of oxygen(GO:0003032) |
0.8 | 3.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.8 | 4.5 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.8 | 4.5 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.8 | 38.6 | GO:0007498 | mesoderm development(GO:0007498) |
0.8 | 0.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.8 | 1.5 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.8 | 1.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.8 | 39.8 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.7 | 0.7 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.7 | 0.7 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.7 | 8.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.7 | 0.7 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.7 | 2.2 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.7 | 2.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.7 | 0.7 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.7 | 1.5 | GO:0019042 | viral latency(GO:0019042) |
0.7 | 2.9 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.7 | 0.7 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.7 | 0.7 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.7 | 2.9 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.7 | 2.9 | GO:1903076 | regulation of establishment of protein localization to plasma membrane(GO:0090003) regulation of protein localization to plasma membrane(GO:1903076) regulation of protein localization to cell periphery(GO:1904375) |
0.7 | 2.9 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.7 | 0.7 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.7 | 1.5 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.7 | 5.1 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.7 | 5.8 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.7 | 2.2 | GO:0070265 | necrotic cell death(GO:0070265) |
0.7 | 1.4 | GO:1901623 | T cell chemotaxis(GO:0010818) regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) regulation of lymphocyte chemotaxis(GO:1901623) regulation of lymphocyte migration(GO:2000401) positive regulation of lymphocyte migration(GO:2000403) regulation of T cell migration(GO:2000404) positive regulation of T cell migration(GO:2000406) |
0.7 | 2.1 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.7 | 2.8 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.7 | 0.7 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.7 | 1.4 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.7 | 9.9 | GO:0090317 | negative regulation of intracellular protein transport(GO:0090317) |
0.7 | 7.8 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.7 | 7.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.7 | 5.6 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.7 | 2.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.7 | 3.5 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.7 | 4.2 | GO:0045725 | positive regulation of glucose metabolic process(GO:0010907) positive regulation of glycogen biosynthetic process(GO:0045725) |
0.7 | 2.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.7 | 4.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.7 | 1.4 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.7 | 18.5 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.7 | 0.7 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.7 | 2.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.7 | 2.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.7 | 3.4 | GO:0060023 | soft palate development(GO:0060023) |
0.7 | 0.7 | GO:0048302 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
0.7 | 0.7 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.7 | 7.4 | GO:0051607 | defense response to virus(GO:0051607) |
0.7 | 10.2 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.7 | 2.0 | GO:0009301 | snRNA transcription(GO:0009301) |
0.7 | 1.4 | GO:0060179 | male courtship behavior(GO:0008049) male mating behavior(GO:0060179) |
0.7 | 4.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.7 | 2.7 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.7 | 1.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.7 | 2.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.7 | 10.6 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.7 | 2.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.7 | 3.3 | GO:0032925 | regulation of activin receptor signaling pathway(GO:0032925) |
0.7 | 2.6 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.7 | 0.7 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.7 | 2.0 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.7 | 3.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.7 | 7.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.7 | 0.7 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.7 | 1.3 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.7 | 2.6 | GO:0000154 | rRNA modification(GO:0000154) |
0.6 | 0.6 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.6 | 1.3 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.6 | 4.5 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.6 | 1.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.6 | 0.6 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.6 | 3.9 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.6 | 0.6 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.6 | 0.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.6 | 5.7 | GO:0019226 | transmission of nerve impulse(GO:0019226) multicellular organismal signaling(GO:0035637) |
0.6 | 0.6 | GO:0072087 | renal vesicle development(GO:0072087) |
0.6 | 8.3 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.6 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
0.6 | 0.6 | GO:0060992 | response to fungicide(GO:0060992) |
0.6 | 1.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.6 | 1.9 | GO:0010823 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.6 | 2.5 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.6 | 0.6 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.6 | 1.9 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.6 | 1.9 | GO:0015669 | gas transport(GO:0015669) |
0.6 | 1.2 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.6 | 3.7 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.6 | 1.8 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.6 | 0.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.6 | 1.8 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) positive regulation of tooth mineralization(GO:0070172) |
0.6 | 1.2 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
0.6 | 1.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 23.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.6 | 3.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.6 | 4.9 | GO:0001510 | RNA methylation(GO:0001510) |
0.6 | 1.8 | GO:0042940 | D-amino acid transport(GO:0042940) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.6 | 7.8 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.6 | 1.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.6 | 2.4 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.6 | 3.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.6 | 1.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.6 | 4.8 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.6 | 0.6 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.6 | 14.9 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.6 | 2.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.6 | 1.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.6 | 1.2 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.6 | 23.6 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.6 | 4.1 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.6 | 1.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.6 | 0.6 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.6 | 0.6 | GO:1903224 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.6 | 1.7 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.6 | 7.0 | GO:0002792 | negative regulation of peptide secretion(GO:0002792) |
0.6 | 1.7 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.6 | 4.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.6 | 1.7 | GO:0032098 | regulation of appetite(GO:0032098) |
0.6 | 1.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.6 | 7.4 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.6 | 1.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.6 | 4.0 | GO:0019835 | cytolysis(GO:0019835) |
0.6 | 9.1 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.6 | 1.1 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.6 | 3.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.6 | 3.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.6 | 1.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.6 | 1.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.6 | 10.1 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.6 | 1.1 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.6 | 6.2 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.6 | 2.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.6 | 0.6 | GO:0071503 | response to heparin(GO:0071503) |
0.6 | 1.7 | GO:0002076 | osteoblast development(GO:0002076) |
0.6 | 30.7 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.6 | 1.1 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.6 | 8.3 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.6 | 1.1 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.6 | 1.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.6 | 3.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.6 | 10.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.6 | 2.8 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.6 | 11.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.6 | 0.6 | GO:0045651 | regulation of macrophage differentiation(GO:0045649) positive regulation of macrophage differentiation(GO:0045651) |
0.5 | 1.6 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.5 | 1.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.5 | 25.7 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.5 | 2.7 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.5 | 3.8 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.5 | 1.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.5 | 1.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.5 | 1.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.5 | 5.9 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.5 | 1.1 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.5 | 0.5 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.5 | 18.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.5 | 1.1 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.5 | 0.5 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.5 | 5.8 | GO:0007032 | endosome organization(GO:0007032) |
0.5 | 0.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 0.5 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.5 | 9.0 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.5 | 10.5 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.5 | 1.0 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.5 | 1.6 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.5 | 2.1 | GO:1901222 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.5 | 1.0 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
0.5 | 1.0 | GO:0032418 | lysosome localization(GO:0032418) |
0.5 | 3.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.5 | 0.5 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.5 | 2.6 | GO:0015904 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.5 | 2.6 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.5 | 4.1 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.5 | 1.5 | GO:0021702 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.5 | 1.0 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.5 | 1.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.5 | 49.2 | GO:0048011 | neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.5 | 11.7 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.5 | 1.5 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
0.5 | 3.5 | GO:0015074 | DNA integration(GO:0015074) |
0.5 | 5.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.5 | 1.5 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.5 | 6.1 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.5 | 2.5 | GO:0006983 | ER overload response(GO:0006983) |
0.5 | 4.5 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.5 | 3.0 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.5 | 1.5 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.5 | 2.0 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.5 | 2.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.5 | 4.0 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.5 | 6.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.5 | 1.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.5 | 1.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 1.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.5 | 2.0 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.5 | 2.0 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.5 | 1.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.5 | 0.5 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.5 | 0.5 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.5 | 2.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.5 | 1.9 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.5 | 1.0 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.5 | 5.8 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.5 | 4.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.5 | 3.4 | GO:0000050 | urea cycle(GO:0000050) |
0.5 | 0.5 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) |
0.5 | 0.5 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.5 | 107.2 | GO:0006397 | mRNA processing(GO:0006397) |
0.5 | 1.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.5 | 0.5 | GO:0045006 | DNA deamination(GO:0045006) |
0.5 | 1.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.5 | 0.5 | GO:0048665 | neuron fate specification(GO:0048665) |
0.5 | 0.9 | GO:0016559 | peroxisome fission(GO:0016559) |
0.5 | 0.5 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.5 | 10.7 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.5 | 0.9 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.5 | 0.9 | GO:0006913 | nucleocytoplasmic transport(GO:0006913) |
0.5 | 0.9 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.5 | 0.5 | GO:0032844 | positive regulation of intracellular transport(GO:0032388) regulation of homeostatic process(GO:0032844) |
0.5 | 2.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.5 | 0.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.5 | 2.7 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.5 | 3.2 | GO:0031396 | regulation of protein ubiquitination(GO:0031396) |
0.5 | 2.3 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) peptidyl-histidine modification(GO:0018202) |
0.5 | 0.5 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.5 | 0.9 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.5 | 2.3 | GO:0042098 | T cell proliferation(GO:0042098) |
0.5 | 0.5 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.5 | 1.4 | GO:0050955 | thermoception(GO:0050955) |
0.5 | 5.0 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.5 | 1.4 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.5 | 4.5 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.5 | 0.5 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.4 | 1.3 | GO:0042311 | vasodilation(GO:0042311) |
0.4 | 0.4 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.4 | 0.9 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.4 | 0.4 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.4 | 2.2 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.4 | 4.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.4 | 1.8 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.4 | 2.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.4 | 0.4 | GO:0033622 | integrin activation(GO:0033622) |
0.4 | 1.8 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.4 | 2.6 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.4 | 0.4 | GO:0002719 | negative regulation of cytokine production involved in immune response(GO:0002719) |
0.4 | 1.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.4 | 1.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.4 | 1.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.4 | 1.7 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.4 | 3.9 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.4 | 2.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.4 | 3.4 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
0.4 | 0.4 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.4 | 0.9 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.4 | 0.4 | GO:0015872 | dopamine transport(GO:0015872) |
0.4 | 1.7 | GO:0002097 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.4 | 1.3 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.4 | 0.4 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) |
0.4 | 1.3 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 0.4 | GO:1903306 | negative regulation of regulated secretory pathway(GO:1903306) |
0.4 | 1.2 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.4 | 0.4 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.4 | 2.5 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.4 | 1.7 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.4 | 3.7 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.4 | 0.8 | GO:1903319 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.4 | 14.3 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.4 | 4.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.4 | 2.4 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.4 | 0.4 | GO:0031297 | replication fork processing(GO:0031297) |
0.4 | 5.3 | GO:0030183 | B cell differentiation(GO:0030183) |
0.4 | 4.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.4 | 1.2 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.4 | 1.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.4 | 1.6 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.4 | 2.0 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.4 | 1.6 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.4 | 1.6 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.4 | 3.2 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.4 | 1.2 | GO:0001832 | blastocyst growth(GO:0001832) |
0.4 | 1.2 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.4 | 1.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.4 | 1.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 1.6 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.4 | 6.0 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.4 | 0.4 | GO:0002385 | innate immune response in mucosa(GO:0002227) mucosal immune response(GO:0002385) |
0.4 | 0.4 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
0.4 | 1.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.4 | 3.2 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.4 | 0.4 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.4 | 1.6 | GO:0021854 | hypothalamus development(GO:0021854) |
0.4 | 0.4 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.4 | 0.4 | GO:0051608 | histamine transport(GO:0051608) |
0.4 | 0.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.4 | 0.4 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.4 | 1.2 | GO:0016458 | gene silencing(GO:0016458) |
0.4 | 0.4 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.4 | 1.9 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.4 | 1.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.4 | 0.4 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.4 | 3.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.4 | 15.0 | GO:0034340 | response to type I interferon(GO:0034340) |
0.4 | 0.8 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.4 | 4.2 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.4 | 0.4 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) cilium movement involved in cell motility(GO:0060294) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.4 | 1.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.4 | 0.4 | GO:0045821 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.4 | 1.5 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.4 | 0.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.4 | 1.1 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.4 | 0.8 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.4 | 4.9 | GO:0098781 | rRNA transcription(GO:0009303) ncRNA transcription(GO:0098781) |
0.4 | 0.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.4 | 0.4 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.4 | 1.1 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.4 | 0.4 | GO:0048278 | vesicle docking(GO:0048278) |
0.4 | 0.7 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.4 | 0.4 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.4 | 1.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.4 | 0.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.4 | 1.5 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.4 | 0.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.4 | 0.4 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.4 | 1.5 | GO:0090399 | replicative senescence(GO:0090399) |
0.4 | 1.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.4 | 0.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.4 | 2.9 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.4 | 1.4 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.4 | 11.1 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.4 | 1.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.4 | 0.4 | GO:0072659 | protein localization to plasma membrane(GO:0072659) protein localization to cell periphery(GO:1990778) |
0.4 | 1.1 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.4 | 3.2 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.4 | 3.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.4 | 1.4 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.4 | 0.4 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.4 | 2.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.3 | 10.1 | GO:0051028 | mRNA transport(GO:0051028) |
0.3 | 1.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 1.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 3.5 | GO:0007379 | segment specification(GO:0007379) |
0.3 | 0.7 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.3 | 0.7 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.3 | 2.1 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.3 | 1.0 | GO:0048069 | eye pigmentation(GO:0048069) |
0.3 | 7.6 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.3 | 3.5 | GO:0007254 | JNK cascade(GO:0007254) |
0.3 | 12.4 | GO:0097194 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) execution phase of apoptosis(GO:0097194) |
0.3 | 0.3 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.3 | 1.4 | GO:0002250 | adaptive immune response(GO:0002250) |
0.3 | 0.7 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.3 | 1.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 3.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 32.4 | GO:0050776 | regulation of immune response(GO:0050776) |
0.3 | 0.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.3 | 3.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.3 | 1.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.3 | 1.0 | GO:0071569 | protein ufmylation(GO:0071569) |
0.3 | 1.4 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.3 | 2.0 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.3 | 0.7 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.3 | 33.7 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.3 | 1.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.3 | 7.0 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.3 | 33.6 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.3 | 0.7 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.3 | 5.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.3 | 0.3 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.3 | 0.7 | GO:0001881 | receptor recycling(GO:0001881) |
0.3 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.3 | 4.2 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.3 | 0.3 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.3 | 1.9 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.3 | 3.2 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.3 | 0.3 | GO:0000239 | pachytene(GO:0000239) |
0.3 | 0.3 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) |
0.3 | 3.8 | GO:0008380 | RNA splicing(GO:0008380) |
0.3 | 1.6 | GO:0035601 | protein deacylation(GO:0035601) macromolecule deacylation(GO:0098732) |
0.3 | 0.6 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.3 | 1.9 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 0.9 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.3 | 2.2 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.3 | 0.6 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.3 | 0.3 | GO:0001302 | replicative cell aging(GO:0001302) |
0.3 | 0.6 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.3 | 0.3 | GO:1903725 | regulation of phospholipid metabolic process(GO:1903725) |
0.3 | 0.6 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.3 | 0.3 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.3 | 2.8 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.3 | 0.6 | GO:0001935 | endothelial cell proliferation(GO:0001935) |
0.3 | 0.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 0.3 | GO:0006664 | glycolipid metabolic process(GO:0006664) |
0.3 | 0.6 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.3 | 0.3 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.3 | 0.6 | GO:0007000 | nucleolus organization(GO:0007000) |
0.3 | 3.4 | GO:0006959 | humoral immune response(GO:0006959) |
0.3 | 4.6 | GO:0001906 | cell killing(GO:0001906) |
0.3 | 1.2 | GO:0007140 | male meiosis(GO:0007140) |
0.3 | 0.3 | GO:0051318 | G1 phase(GO:0051318) |
0.3 | 2.7 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.3 | 1.5 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.3 | 0.6 | GO:0032635 | interleukin-6 production(GO:0032635) |
0.3 | 1.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 0.6 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.3 | 3.6 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.3 | 0.3 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.3 | 3.6 | GO:1902653 | secondary alcohol biosynthetic process(GO:1902653) |
0.3 | 0.3 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.3 | 0.6 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.3 | 0.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.3 | 0.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.3 | 2.7 | GO:0034765 | regulation of ion transmembrane transport(GO:0034765) |
0.3 | 0.9 | GO:0003407 | neural retina development(GO:0003407) |
0.3 | 2.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.3 | 1.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.3 | 2.0 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.3 | 0.6 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.3 | 0.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 2.3 | GO:1903305 | regulation of calcium ion-dependent exocytosis(GO:0017158) regulation of regulated secretory pathway(GO:1903305) |
0.3 | 0.6 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.3 | 0.3 | GO:0001974 | blood vessel remodeling(GO:0001974) |
0.3 | 0.6 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.3 | 0.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.3 | 0.6 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.3 | 0.9 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.3 | 4.0 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.3 | 1.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 1.7 | GO:0016445 | somatic diversification of immune receptors(GO:0002200) somatic diversification of immunoglobulins(GO:0016445) |
0.3 | 4.0 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.3 | 2.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.3 | 4.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.3 | 0.3 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.3 | 1.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.3 | 0.3 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 0.3 | GO:0021754 | facial nucleus development(GO:0021754) |
0.3 | 0.3 | GO:0032202 | telomere assembly(GO:0032202) |
0.3 | 1.4 | GO:0042596 | behavioral fear response(GO:0001662) fear response(GO:0042596) |
0.3 | 81.3 | GO:0006412 | translation(GO:0006412) |
0.3 | 3.3 | GO:1903037 | regulation of T cell activation(GO:0050863) regulation of leukocyte cell-cell adhesion(GO:1903037) |
0.3 | 1.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 0.8 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.3 | 0.6 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.3 | 3.0 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.3 | 1.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 4.9 | GO:0007030 | Golgi organization(GO:0007030) |
0.3 | 0.5 | GO:1902806 | regulation of cell cycle G1/S phase transition(GO:1902806) regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.3 | 1.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.3 | 5.7 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.3 | 0.5 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.3 | 6.0 | GO:0044782 | cilium organization(GO:0044782) |
0.3 | 0.3 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.3 | 4.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.3 | 0.3 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.3 | 0.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.3 | 0.3 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.3 | 2.1 | GO:0030317 | sperm motility(GO:0030317) |
0.3 | 2.6 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.3 | 2.1 | GO:0016925 | protein sumoylation(GO:0016925) |
0.3 | 0.8 | GO:0002063 | chondrocyte development(GO:0002063) |
0.3 | 0.5 | GO:0032288 | myelin assembly(GO:0032288) |
0.3 | 0.3 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.3 | 0.3 | GO:0003016 | respiratory system process(GO:0003016) |
0.3 | 0.8 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.3 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.3 | 2.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.3 | 0.3 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.3 | 1.5 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) deoxyribose phosphate catabolic process(GO:0046386) |
0.3 | 0.8 | GO:0007512 | adult heart development(GO:0007512) |
0.3 | 3.5 | GO:0016571 | histone methylation(GO:0016571) |
0.3 | 0.5 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.3 | 0.8 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.5 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 2.0 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.2 | 0.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.2 | 8.0 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.2 | 0.2 | GO:0042991 | regulation of transcription factor import into nucleus(GO:0042990) transcription factor import into nucleus(GO:0042991) |
0.2 | 1.0 | GO:0030277 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 9.2 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.2 | 2.2 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.2 | 0.5 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.2 | 1.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 0.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.2 | GO:0006282 | regulation of DNA repair(GO:0006282) |
0.2 | 0.2 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.2 | 0.2 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.2 | 1.9 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.2 | 0.7 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.5 | GO:0032094 | response to food(GO:0032094) |
0.2 | 0.2 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 2.2 | GO:0048864 | stem cell development(GO:0048864) |
0.2 | 2.6 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.2 | 9.8 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.2 | 1.0 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.2 | 0.9 | GO:0009749 | response to glucose(GO:0009749) |
0.2 | 0.2 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.2 | 0.9 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 2.1 | GO:0048937 | sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
0.2 | 0.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) regulation of glial cell proliferation(GO:0060251) negative regulation of glial cell proliferation(GO:0060253) |
0.2 | 4.7 | GO:0007051 | spindle organization(GO:0007051) |
0.2 | 5.6 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 0.5 | GO:0032368 | regulation of lipid transport(GO:0032368) |
0.2 | 0.2 | GO:0045851 | pH reduction(GO:0045851) |
0.2 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.5 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.2 | 0.2 | GO:0001820 | serotonin secretion(GO:0001820) |
0.2 | 1.8 | GO:0007530 | sex determination(GO:0007530) |
0.2 | 0.5 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.2 | 0.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 0.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 3.2 | GO:0001764 | neuron migration(GO:0001764) |
0.2 | 1.6 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 0.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 0.5 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.2 | 1.8 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.2 | 2.9 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.2 | GO:0045768 | obsolete positive regulation of anti-apoptosis(GO:0045768) |
0.2 | 0.7 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.2 | 1.6 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.2 | 0.9 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.2 | 3.3 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.2 | 0.7 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.2 | 2.0 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.2 | 1.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.2 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.2 | 1.3 | GO:0098543 | detection of other organism(GO:0098543) |
0.2 | 5.4 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.2 | 1.3 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 0.6 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.2 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.2 | 0.4 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.2 | 0.4 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 4.8 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.2 | 0.2 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.2 | 1.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.2 | 0.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 0.2 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.2 | 1.0 | GO:0044843 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.2 | 0.2 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.2 | 1.9 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.2 | 11.5 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.2 | 3.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.2 | 0.4 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.2 | 2.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.2 | 14.8 | GO:0016568 | chromatin modification(GO:0016568) |
0.2 | 0.4 | GO:0051187 | cofactor catabolic process(GO:0051187) |
0.2 | 0.4 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
0.2 | 0.6 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 15.5 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.2 | 1.6 | GO:0042044 | fluid transport(GO:0042044) |
0.2 | 0.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 0.4 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.2 | 0.6 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.2 | 18.6 | GO:0006457 | protein folding(GO:0006457) |
0.2 | 0.6 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.2 | 0.8 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 0.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 2.1 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.2 | 1.1 | GO:0009268 | response to pH(GO:0009268) |
0.2 | 1.3 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.2 | 0.2 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.2 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.2 | 2.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 0.7 | GO:0051306 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) regulation of mitotic sister chromatid separation(GO:0010965) regulation of sister chromatid segregation(GO:0033045) regulation of mitotic sister chromatid segregation(GO:0033047) metaphase/anaphase transition of cell cycle(GO:0044784) mitotic sister chromatid separation(GO:0051306) |
0.2 | 0.9 | GO:0006325 | chromatin organization(GO:0006325) |
0.2 | 0.2 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.2 | 1.3 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.2 | 0.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.2 | 0.5 | GO:0015853 | adenine transport(GO:0015853) |
0.2 | 0.4 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.2 | 0.5 | GO:0046849 | bone remodeling(GO:0046849) |
0.2 | 0.2 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 2.4 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.2 | 0.4 | GO:0050918 | positive chemotaxis(GO:0050918) |
0.2 | 0.2 | GO:0060677 | ureteric bud elongation(GO:0060677) renal vesicle formation(GO:0072033) |
0.2 | 2.3 | GO:0006887 | exocytosis(GO:0006887) |
0.2 | 0.9 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) |
0.2 | 0.2 | GO:0033504 | floor plate development(GO:0033504) |
0.2 | 0.2 | GO:0043900 | regulation of multi-organism process(GO:0043900) |
0.2 | 0.7 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.2 | 1.1 | GO:1901215 | negative regulation of neuron apoptotic process(GO:0043524) negative regulation of neuron death(GO:1901215) |
0.2 | 0.7 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.2 | 0.2 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.2 | 0.3 | GO:0001706 | endoderm formation(GO:0001706) |
0.2 | 1.7 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.2 | 0.5 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.2 | 1.9 | GO:0006885 | regulation of pH(GO:0006885) |
0.2 | 0.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 0.8 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.2 | 0.2 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.2 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.2 | 0.2 | GO:0048935 | peripheral nervous system neuron development(GO:0048935) |
0.2 | 2.7 | GO:0048285 | organelle fission(GO:0048285) |
0.2 | 0.2 | GO:0002697 | regulation of immune effector process(GO:0002697) |
0.2 | 1.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 0.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 1.5 | GO:0006862 | nucleotide transport(GO:0006862) |
0.2 | 1.3 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.2 | 0.2 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.2 | 0.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.2 | 0.3 | GO:0021543 | pallium development(GO:0021543) |
0.2 | 3.3 | GO:0072655 | establishment of protein localization to mitochondrion(GO:0072655) |
0.2 | 1.4 | GO:0031280 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.2 | 0.2 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.2 | 1.4 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.2 | 0.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.3 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.2 | 3.5 | GO:0006096 | glycolytic process(GO:0006096) ATP generation from ADP(GO:0006757) |
0.2 | 0.9 | GO:0055123 | digestive system development(GO:0055123) |
0.2 | 7.0 | GO:0007586 | digestion(GO:0007586) |
0.2 | 0.2 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.2 | 1.5 | GO:0031345 | negative regulation of neuron projection development(GO:0010977) negative regulation of cell projection organization(GO:0031345) |
0.2 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 0.3 | GO:0048635 | negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle organ development(GO:0048635) negative regulation of muscle tissue development(GO:1901862) |
0.2 | 1.2 | GO:0007259 | JAK-STAT cascade(GO:0007259) STAT cascade(GO:0097696) |
0.2 | 0.5 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.6 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.1 | 0.9 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 0.7 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.1 | 0.1 | GO:0045187 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 1.6 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 1.2 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.1 | 0.3 | GO:0014904 | myotube cell development(GO:0014904) |
0.1 | 0.4 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 1.6 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
0.1 | 0.3 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.1 | 0.3 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 15.2 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 0.1 | GO:0061299 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.1 | GO:1902115 | regulation of organelle assembly(GO:1902115) |
0.1 | 26.3 | GO:0007599 | hemostasis(GO:0007599) |
0.1 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 17.6 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.1 | 0.1 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.1 | 0.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 1.5 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.1 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.8 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.1 | 0.5 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.3 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.1 | 1.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.4 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.1 | GO:0006560 | proline metabolic process(GO:0006560) |
0.1 | 0.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 1.4 | GO:0009791 | post-embryonic development(GO:0009791) |
0.1 | 0.4 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 1.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.1 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.1 | 0.2 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.7 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.6 | GO:0006228 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.1 | 1.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.6 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.1 | 0.4 | GO:0007034 | vacuolar transport(GO:0007034) |
0.1 | 0.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 9.3 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.1 | 0.4 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 3.4 | GO:0045087 | innate immune response(GO:0045087) |
0.1 | 0.8 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.1 | 0.1 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.1 | 0.8 | GO:0046148 | pigment biosynthetic process(GO:0046148) |
0.1 | 1.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.5 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 44.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 1.8 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
0.1 | 0.6 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 0.2 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 1.2 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.1 | 3.8 | GO:0009615 | response to virus(GO:0009615) |
0.1 | 0.3 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.3 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 0.4 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.5 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.1 | 0.1 | GO:0030278 | regulation of ossification(GO:0030278) |
0.1 | 0.1 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.1 | 0.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.2 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.1 | 10.6 | GO:0043632 | modification-dependent macromolecule catabolic process(GO:0043632) |
0.1 | 0.3 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.1 | 1.9 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 1.3 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.1 | GO:0071706 | tumor necrosis factor superfamily cytokine production(GO:0071706) |
0.1 | 1.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.1 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.1 | 0.5 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.1 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 3.2 | GO:0008219 | cell death(GO:0008219) |
0.1 | 9.6 | GO:0006955 | immune response(GO:0006955) |
0.1 | 2.0 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.5 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 0.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.2 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.3 | GO:0007346 | regulation of mitotic cell cycle(GO:0007346) |
0.1 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:0070231 | T cell apoptotic process(GO:0070231) |
0.1 | 0.2 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.9 | GO:0018212 | peptidyl-tyrosine modification(GO:0018212) |
0.1 | 0.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.2 | GO:0016236 | macroautophagy(GO:0016236) |
0.1 | 0.2 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.3 | GO:0007281 | germ cell development(GO:0007281) |
0.1 | 0.1 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.1 | 0.3 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.2 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.1 | 0.4 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.1 | 0.1 | GO:0021675 | nerve development(GO:0021675) |
0.1 | 0.1 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.1 | 0.2 | GO:0045446 | endothelial cell differentiation(GO:0045446) |
0.1 | 0.2 | GO:0046323 | glucose import(GO:0046323) |
0.1 | 0.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 2.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.7 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.1 | 3.0 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.1 | 0.2 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.1 | 0.9 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 1.1 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.1 | 0.1 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 17.3 | GO:0012501 | programmed cell death(GO:0012501) |
0.1 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.1 | GO:0007622 | rhythmic behavior(GO:0007622) circadian behavior(GO:0048512) |
0.1 | 58.6 | GO:0016070 | RNA metabolic process(GO:0016070) |
0.1 | 0.6 | GO:0048477 | oogenesis(GO:0048477) |
0.1 | 0.5 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.1 | GO:0072171 | nephron tubule morphogenesis(GO:0072078) mesonephric tubule morphogenesis(GO:0072171) |
0.1 | 0.3 | GO:0009799 | determination of left/right symmetry(GO:0007368) specification of symmetry(GO:0009799) determination of bilateral symmetry(GO:0009855) |
0.0 | 0.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.1 | GO:0055006 | cardiac cell development(GO:0055006) cardiac muscle cell development(GO:0055013) |
0.0 | 0.3 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.2 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.0 | GO:0032409 | regulation of transporter activity(GO:0032409) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.0 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.0 | 0.1 | GO:0032259 | methylation(GO:0032259) |
0.0 | 0.4 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.0 | 6.2 | GO:0016310 | phosphorylation(GO:0016310) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 4.4 | GO:0015031 | protein transport(GO:0015031) |
0.0 | 0.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.2 | GO:0006071 | glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.8 | 20.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
4.3 | 34.5 | GO:0001891 | phagocytic cup(GO:0001891) |
2.9 | 8.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
2.8 | 2.8 | GO:0030880 | RNA polymerase complex(GO:0030880) |
2.6 | 7.8 | GO:0005884 | actin filament(GO:0005884) |
2.5 | 7.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
2.5 | 5.0 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
2.5 | 10.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
2.4 | 26.7 | GO:0001772 | immunological synapse(GO:0001772) |
2.4 | 29.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
2.4 | 14.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
2.3 | 4.6 | GO:0031932 | TORC2 complex(GO:0031932) |
2.2 | 31.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
2.2 | 6.6 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
2.2 | 6.5 | GO:0072487 | MSL complex(GO:0072487) |
2.1 | 19.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.9 | 5.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.7 | 5.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.7 | 6.8 | GO:0005827 | polar microtubule(GO:0005827) |
1.7 | 8.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
1.7 | 16.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.6 | 4.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.6 | 8.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.6 | 8.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.6 | 7.8 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.5 | 22.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
1.5 | 12.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
1.5 | 1.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.5 | 6.0 | GO:0043218 | compact myelin(GO:0043218) |
1.5 | 4.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.5 | 4.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.4 | 8.7 | GO:0000791 | euchromatin(GO:0000791) |
1.4 | 4.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.4 | 4.1 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
1.4 | 5.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
1.4 | 1.4 | GO:0031090 | organelle membrane(GO:0031090) |
1.3 | 3.9 | GO:0032009 | early phagosome(GO:0032009) |
1.3 | 44.4 | GO:0030175 | filopodium(GO:0030175) |
1.3 | 2.5 | GO:0012505 | endomembrane system(GO:0012505) |
1.2 | 4.9 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
1.2 | 11.1 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
1.2 | 12.1 | GO:0045120 | pronucleus(GO:0045120) |
1.2 | 7.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.2 | 23.6 | GO:0031519 | PcG protein complex(GO:0031519) |
1.2 | 18.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
1.2 | 11.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
1.1 | 2.3 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
1.1 | 2.3 | GO:0031904 | endosome lumen(GO:0031904) |
1.1 | 6.6 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.1 | 49.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
1.1 | 3.3 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
1.1 | 4.4 | GO:0005667 | transcription factor complex(GO:0005667) |
1.1 | 3.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
1.1 | 3.2 | GO:0001652 | granular component(GO:0001652) |
1.1 | 1.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.1 | 6.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.1 | 2.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
1.1 | 3.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.0 | 10.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
1.0 | 6.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
1.0 | 6.2 | GO:0042382 | paraspeckles(GO:0042382) |
1.0 | 6.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
1.0 | 12.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
1.0 | 11.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.0 | 4.1 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
1.0 | 3.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.0 | 3.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.0 | 3.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.0 | 7.8 | GO:0043209 | myelin sheath(GO:0043209) |
1.0 | 30.1 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
1.0 | 2.9 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
1.0 | 13.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
1.0 | 2.9 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.9 | 0.9 | GO:0032040 | small-subunit processome(GO:0032040) |
0.9 | 16.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.9 | 2.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.9 | 2.8 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.9 | 0.9 | GO:0042827 | platelet dense granule(GO:0042827) |
0.9 | 19.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.9 | 3.7 | GO:0001740 | Barr body(GO:0001740) |
0.9 | 3.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.9 | 6.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.9 | 5.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.9 | 0.9 | GO:0044309 | neuron spine(GO:0044309) |
0.9 | 10.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.9 | 1.8 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.9 | 2.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.9 | 6.2 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.9 | 4.4 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.9 | 2.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.9 | 3.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.9 | 6.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.9 | 1.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.9 | 6.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.9 | 3.4 | GO:0005638 | lamin filament(GO:0005638) |
0.9 | 4.3 | GO:0070695 | FHF complex(GO:0070695) |
0.9 | 12.0 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.8 | 5.9 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.8 | 2.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.8 | 5.0 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.8 | 7.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.8 | 3.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.8 | 16.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.8 | 1.6 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.8 | 8.7 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.8 | 0.8 | GO:0071547 | piP-body(GO:0071547) |
0.8 | 2.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.8 | 0.8 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.8 | 3.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.8 | 14.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.8 | 2.3 | GO:0016589 | NURF complex(GO:0016589) |
0.8 | 21.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.8 | 3.0 | GO:0001741 | XY body(GO:0001741) |
0.7 | 1.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.7 | 8.9 | GO:0005844 | polysome(GO:0005844) |
0.7 | 3.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.7 | 4.5 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.7 | 8.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.7 | 87.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.7 | 0.7 | GO:0042555 | MCM complex(GO:0042555) |
0.7 | 5.9 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.7 | 2.2 | GO:0071942 | XPC complex(GO:0071942) |
0.7 | 15.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.7 | 6.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.7 | 0.7 | GO:0030496 | midbody(GO:0030496) |
0.7 | 2.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.7 | 5.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.7 | 0.7 | GO:0030870 | Mre11 complex(GO:0030870) |
0.7 | 2.1 | GO:0034464 | BBSome(GO:0034464) |
0.7 | 35.2 | GO:0016605 | PML body(GO:0016605) |
0.7 | 0.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.7 | 1.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.7 | 0.7 | GO:0030684 | preribosome(GO:0030684) |
0.7 | 4.1 | GO:0045179 | apical cortex(GO:0045179) |
0.7 | 2.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.7 | 11.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.7 | 5.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.6 | 0.6 | GO:0044447 | axoneme part(GO:0044447) |
0.6 | 2.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.6 | 1.3 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.6 | 32.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.6 | 10.7 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.6 | 0.6 | GO:0030312 | external encapsulating structure(GO:0030312) external encapsulating structure part(GO:0044462) |
0.6 | 48.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.6 | 3.7 | GO:0042627 | chylomicron(GO:0042627) |
0.6 | 5.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.6 | 1.2 | GO:0032449 | CBM complex(GO:0032449) |
0.6 | 2.5 | GO:0000346 | transcription export complex(GO:0000346) |
0.6 | 14.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.6 | 0.6 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.6 | 3.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.6 | 27.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.6 | 5.5 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.6 | 3.0 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.6 | 1.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.6 | 1.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.6 | 3.6 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.6 | 0.6 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.6 | 26.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.6 | 1.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.6 | 2.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.6 | 17.9 | GO:0016592 | mediator complex(GO:0016592) |
0.6 | 1.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.6 | 1.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.5 | 21.4 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.5 | 6.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 1.6 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.5 | 0.5 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.5 | 6.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.5 | 1.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 3.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.5 | 2.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.5 | 12.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.5 | 1.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.5 | 5.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.5 | 2.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.5 | 5.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.5 | 5.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.5 | 4.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.5 | 3.0 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) |
0.5 | 3.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.5 | 2.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.5 | 1.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 61.1 | GO:0000785 | chromatin(GO:0000785) |
0.5 | 6.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.5 | 1.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.5 | 2.4 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.5 | 2.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.5 | 2.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.5 | 1.9 | GO:0000796 | condensin complex(GO:0000796) |
0.5 | 1.9 | GO:0033011 | perinuclear theca(GO:0033011) |
0.5 | 1.9 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.5 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.5 | 4.1 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.5 | 40.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.5 | 1.8 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.5 | 4.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.5 | 13.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.4 | 4.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.4 | 26.8 | GO:0099568 | cytoplasmic region(GO:0099568) |
0.4 | 2.7 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.4 | 0.9 | GO:0016235 | aggresome(GO:0016235) |
0.4 | 3.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.4 | 6.4 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.4 | 8.1 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 20.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.4 | 2.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 6.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.4 | 1.6 | GO:0005902 | microvillus(GO:0005902) |
0.4 | 0.8 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.4 | 14.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.4 | 10.0 | GO:0005921 | gap junction(GO:0005921) |
0.4 | 6.8 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.4 | 11.5 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.4 | 4.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.4 | 21.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.4 | 0.8 | GO:0071817 | MMXD complex(GO:0071817) |
0.4 | 1.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.4 | 11.2 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.4 | 22.4 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.4 | 109.9 | GO:0005768 | endosome(GO:0005768) |
0.4 | 4.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.4 | 1.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 1.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 1.5 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.4 | 3.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 4.8 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.4 | 4.3 | GO:1902493 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.4 | 2.2 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.4 | 1.4 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.4 | 4.6 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.4 | 1.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.4 | 283.8 | GO:0005730 | nucleolus(GO:0005730) |
0.4 | 4.6 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.4 | 0.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.4 | 7.1 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.4 | 3.9 | GO:0030286 | dynein complex(GO:0030286) |
0.4 | 1.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 0.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.3 | 0.7 | GO:0030120 | vesicle coat(GO:0030120) |
0.3 | 1.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 0.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.3 | 1.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 1.7 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.3 | 2.0 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.3 | 1.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 1.3 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.3 | 2.3 | GO:0016528 | sarcoplasm(GO:0016528) sarcoplasmic reticulum(GO:0016529) |
0.3 | 0.7 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 7.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 3.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 140.1 | GO:0005654 | nucleoplasm(GO:0005654) |
0.3 | 18.5 | GO:0019867 | outer membrane(GO:0019867) |
0.3 | 356.2 | GO:0005829 | cytosol(GO:0005829) |
0.3 | 1.5 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.3 | 0.3 | GO:0044304 | main axon(GO:0044304) |
0.3 | 8.3 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.3 | 1.2 | GO:0030992 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.3 | 33.7 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.3 | 2.3 | GO:0030313 | cell envelope(GO:0030313) |
0.3 | 5.4 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.3 | 683.0 | GO:0005634 | nucleus(GO:0005634) |
0.3 | 4.4 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.3 | 0.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.3 | 1.9 | GO:0005840 | ribosome(GO:0005840) |
0.3 | 14.9 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.3 | 1.0 | GO:0044427 | chromosomal part(GO:0044427) |
0.3 | 98.6 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.3 | 2.8 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.3 | 1.0 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 1.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 25.2 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.2 | 0.2 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.2 | 47.7 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 1.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 1.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 0.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 0.4 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.2 | 2.4 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.2 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 1.0 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 33.8 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.2 | 14.6 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.2 | 75.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 0.2 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 548.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.2 | 1.8 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.2 | 7.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 0.7 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.2 | 0.2 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.6 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 3.1 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.1 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.1 | 0.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.1 | GO:0034358 | protein-lipid complex(GO:0032994) plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.1 | 0.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.4 | GO:0098797 | plasma membrane protein complex(GO:0098797) |
0.1 | 0.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.2 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 0.1 | GO:0098793 | presynapse(GO:0098793) |
0.1 | 0.1 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.6 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.2 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 48.9 | GO:0005622 | intracellular(GO:0005622) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.2 | 21.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
5.7 | 17.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
5.4 | 16.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
5.1 | 15.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
4.4 | 26.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
4.4 | 44.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
4.4 | 17.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
4.4 | 52.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
4.1 | 12.4 | GO:0033691 | sialic acid binding(GO:0033691) |
4.1 | 12.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
3.9 | 11.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
3.9 | 11.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
3.6 | 10.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
3.5 | 17.6 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
3.1 | 21.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
2.9 | 5.9 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
2.6 | 7.9 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
2.6 | 10.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
2.6 | 60.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
2.6 | 10.5 | GO:0015925 | galactosidase activity(GO:0015925) |
2.6 | 13.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
2.5 | 7.6 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
2.5 | 7.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
2.5 | 22.5 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
2.4 | 7.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.4 | 7.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
2.2 | 9.0 | GO:0004527 | exonuclease activity(GO:0004527) |
2.2 | 6.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.2 | 6.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
2.2 | 13.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
2.2 | 2.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) phosphatidylinositol-4-phosphate binding(GO:0070273) |
2.2 | 28.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
2.1 | 6.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
2.0 | 8.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.9 | 31.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.9 | 13.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.8 | 9.2 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
1.8 | 16.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
1.8 | 5.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
1.8 | 5.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
1.8 | 5.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.8 | 14.3 | GO:0030332 | cyclin binding(GO:0030332) |
1.8 | 33.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
1.7 | 5.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.7 | 5.2 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
1.7 | 6.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
1.7 | 20.7 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
1.7 | 62.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.7 | 13.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.7 | 80.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.6 | 13.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
1.6 | 9.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.6 | 20.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
1.6 | 3.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.5 | 3.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
1.5 | 7.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.5 | 6.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.5 | 6.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
1.5 | 4.4 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
1.5 | 24.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.5 | 4.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
1.5 | 18.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
1.4 | 8.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.4 | 11.4 | GO:0005522 | profilin binding(GO:0005522) |
1.4 | 4.2 | GO:0035197 | siRNA binding(GO:0035197) |
1.4 | 8.5 | GO:0070513 | death domain binding(GO:0070513) |
1.4 | 11.0 | GO:0046625 | sphingolipid binding(GO:0046625) |
1.4 | 4.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.4 | 10.9 | GO:0003785 | actin monomer binding(GO:0003785) |
1.4 | 9.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
1.3 | 2.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.3 | 14.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
1.3 | 8.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.3 | 12.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.3 | 6.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.3 | 4.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.3 | 6.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
1.3 | 6.5 | GO:0031013 | troponin I binding(GO:0031013) |
1.3 | 22.2 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
1.3 | 1.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.3 | 33.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
1.3 | 5.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
1.3 | 3.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.3 | 5.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
1.3 | 6.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.3 | 35.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
1.2 | 1.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
1.2 | 10.0 | GO:0050700 | CARD domain binding(GO:0050700) |
1.2 | 1.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.2 | 4.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.2 | 6.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.2 | 8.5 | GO:0004568 | chitinase activity(GO:0004568) |
1.2 | 1.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.2 | 7.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.2 | 6.0 | GO:0031996 | thioesterase binding(GO:0031996) |
1.2 | 3.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
1.2 | 4.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
1.2 | 13.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.2 | 1.2 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
1.1 | 7.9 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
1.1 | 39.5 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
1.1 | 6.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.1 | 5.6 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.1 | 7.8 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
1.1 | 60.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.1 | 5.5 | GO:0004904 | interferon receptor activity(GO:0004904) |
1.1 | 3.3 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
1.1 | 3.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.1 | 1.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
1.1 | 4.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.1 | 5.4 | GO:0034452 | dynactin binding(GO:0034452) |
1.1 | 3.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.1 | 5.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
1.1 | 3.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
1.1 | 2.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.1 | 11.7 | GO:0008373 | sialyltransferase activity(GO:0008373) |
1.0 | 32.5 | GO:0003823 | antigen binding(GO:0003823) |
1.0 | 4.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.0 | 9.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.0 | 4.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
1.0 | 4.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.0 | 5.2 | GO:0050733 | RS domain binding(GO:0050733) |
1.0 | 3.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
1.0 | 3.0 | GO:0042166 | acetylcholine binding(GO:0042166) |
1.0 | 5.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.0 | 10.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
1.0 | 4.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
1.0 | 10.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.0 | 1.0 | GO:0043398 | HLH domain binding(GO:0043398) |
1.0 | 12.0 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
1.0 | 7.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.0 | 6.9 | GO:0008494 | translation activator activity(GO:0008494) |
1.0 | 3.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
1.0 | 3.0 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
1.0 | 2.9 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
1.0 | 10.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.0 | 1.9 | GO:0060229 | lipase activator activity(GO:0060229) |
1.0 | 2.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.9 | 5.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.9 | 50.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.9 | 0.9 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.9 | 3.8 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.9 | 2.8 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.9 | 14.9 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.9 | 6.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.9 | 0.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.9 | 5.5 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.9 | 6.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.9 | 2.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.9 | 3.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.9 | 7.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.9 | 2.7 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.9 | 2.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.9 | 23.1 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.9 | 6.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.9 | 0.9 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.9 | 2.6 | GO:0005113 | patched binding(GO:0005113) |
0.9 | 5.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.9 | 2.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.9 | 11.1 | GO:0010181 | FMN binding(GO:0010181) |
0.8 | 4.2 | GO:0005521 | lamin binding(GO:0005521) |
0.8 | 11.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.8 | 5.9 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.8 | 7.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.8 | 1.7 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.8 | 2.5 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.8 | 2.5 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.8 | 3.3 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.8 | 4.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.8 | 1.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.8 | 9.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.8 | 3.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.8 | 3.2 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.8 | 4.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.8 | 10.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.8 | 4.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.8 | 2.4 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.8 | 3.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.8 | 0.8 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.8 | 0.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.8 | 2.4 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.8 | 3.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.8 | 10.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.8 | 3.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.8 | 10.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.8 | 7.0 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.8 | 2.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.8 | 0.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.8 | 0.8 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.8 | 8.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.8 | 9.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.8 | 9.9 | GO:0043621 | protein self-association(GO:0043621) |
0.8 | 11.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.8 | 4.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.7 | 12.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.7 | 7.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.7 | 1.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.7 | 3.0 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.7 | 21.4 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.7 | 3.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.7 | 3.7 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.7 | 2.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.7 | 5.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.7 | 15.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.7 | 1.4 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.7 | 14.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.7 | 2.2 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.7 | 2.9 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.7 | 2.8 | GO:0030911 | TPR domain binding(GO:0030911) |
0.7 | 2.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.7 | 16.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.7 | 4.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.7 | 2.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.7 | 3.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.7 | 3.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.7 | 2.1 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.7 | 8.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.7 | 2.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.7 | 4.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.7 | 14.5 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.7 | 4.8 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.7 | 55.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.7 | 3.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.7 | 2.7 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.7 | 0.7 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.7 | 1.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.7 | 1.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.7 | 1.3 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.7 | 3.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.7 | 1.3 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.6 | 1.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.6 | 1.9 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.6 | 1.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.6 | 5.8 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.6 | 3.2 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.6 | 2.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.6 | 8.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.6 | 1.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.6 | 2.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.6 | 1.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.6 | 3.8 | GO:0061659 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.6 | 4.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.6 | 0.6 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.6 | 3.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.6 | 12.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.6 | 2.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.6 | 2.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.6 | 1.8 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.6 | 2.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.6 | 3.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.6 | 1.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.6 | 1.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.6 | 4.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.6 | 8.9 | GO:0002039 | p53 binding(GO:0002039) |
0.6 | 2.4 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.6 | 1.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.6 | 1.8 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.6 | 7.6 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.6 | 2.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.6 | 4.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.6 | 1.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.6 | 1.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.6 | 0.6 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.6 | 1.7 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.6 | 5.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 6.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.6 | 7.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.6 | 14.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.6 | 25.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.6 | 1.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.6 | 2.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.6 | 0.6 | GO:0044620 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.6 | 5.7 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.6 | 7.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.6 | 2.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.6 | 1.7 | GO:0004802 | transketolase activity(GO:0004802) |
0.6 | 2.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.6 | 4.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 19.2 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.5 | 1.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.5 | 2.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.5 | 1.1 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.5 | 12.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.5 | 3.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.5 | 2.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.5 | 2.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.5 | 0.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.5 | 2.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.5 | 2.6 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.5 | 0.5 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.5 | 13.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.5 | 1.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.5 | 1.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.5 | 6.8 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.5 | 2.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.5 | 1.6 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.5 | 6.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 5.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.5 | 3.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.5 | 1.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.5 | 2.5 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.5 | 54.0 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.5 | 1.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.5 | 4.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.5 | 5.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.5 | 0.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.5 | 3.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.5 | 1.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.5 | 15.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.5 | 0.5 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.5 | 2.0 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.5 | 2.4 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.5 | 15.0 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.5 | 1.9 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.5 | 11.5 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.5 | 2.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.5 | 1.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.5 | 1.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.5 | 1.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 20.3 | GO:0042393 | histone binding(GO:0042393) |
0.5 | 1.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.5 | 2.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.5 | 4.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.5 | 0.9 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.5 | 3.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 6.3 | GO:0005048 | signal sequence binding(GO:0005048) |
0.4 | 1.7 | GO:0031432 | titin binding(GO:0031432) |
0.4 | 4.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.4 | 5.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.4 | 1.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 3.0 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.4 | 5.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 20.6 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.4 | 3.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.4 | 0.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 3.8 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.4 | 1.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.4 | 8.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.4 | 2.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.4 | 0.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 8.4 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.4 | 0.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.4 | 0.8 | GO:0005035 | death receptor activity(GO:0005035) |
0.4 | 1.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.4 | 0.8 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.4 | 0.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.4 | 5.0 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.4 | 7.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.4 | 1.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 1.6 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.4 | 1.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.4 | 238.9 | GO:0003723 | RNA binding(GO:0003723) |
0.4 | 7.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.4 | 1.2 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.4 | 121.5 | GO:0005525 | GTP binding(GO:0005525) |
0.4 | 2.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 1.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 1.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 3.6 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.4 | 1.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 0.4 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.4 | 2.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.4 | 2.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 1.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.4 | 1.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.4 | 1.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 1.9 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.4 | 3.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.4 | 0.4 | GO:0003896 | DNA primase activity(GO:0003896) |
0.4 | 1.1 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.4 | 9.4 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.4 | 1.1 | GO:0016208 | AMP binding(GO:0016208) |
0.4 | 0.4 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.4 | 0.4 | GO:0042806 | fucose binding(GO:0042806) |
0.4 | 7.7 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.4 | 1.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 1.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.4 | 7.3 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.4 | 2.2 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.4 | 0.7 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.4 | 2.2 | GO:0043176 | amine binding(GO:0043176) |
0.4 | 1.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 0.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.4 | 1.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.4 | 5.7 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.4 | 14.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 2.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.4 | 2.5 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.3 | 10.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.3 | 0.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.3 | 1.0 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.3 | 3.4 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.3 | 52.8 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.3 | 26.3 | GO:0003682 | chromatin binding(GO:0003682) |
0.3 | 3.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 0.3 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.3 | 0.7 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.3 | 2.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.3 | 2.3 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.3 | 1.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.3 | 1.0 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 1.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 32.9 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.3 | 1.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 1.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 0.6 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 12.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.3 | 2.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 2.6 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.3 | 1.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.3 | 7.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.3 | 1.3 | GO:0070061 | fructose binding(GO:0070061) |
0.3 | 2.8 | GO:0019864 | IgG binding(GO:0019864) |
0.3 | 2.8 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.3 | 4.1 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.3 | 1.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 1.6 | GO:0019001 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.3 | 0.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.3 | 19.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.3 | 0.9 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.3 | 0.6 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 0.3 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.3 | 0.9 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.3 | 8.9 | GO:0044389 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.3 | 0.9 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.3 | 0.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 1.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 3.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 60.8 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.3 | 1.4 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.3 | 4.0 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.3 | 0.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.3 | 469.6 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.3 | 1.4 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.3 | 4.8 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.3 | 0.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 0.6 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.3 | 1.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 0.8 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.3 | 2.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 1.4 | GO:0015923 | mannosidase activity(GO:0015923) |
0.3 | 1.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 8.6 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.3 | 0.5 | GO:0004875 | complement receptor activity(GO:0004875) |
0.3 | 0.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 0.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 1.6 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.3 | 0.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 0.3 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.3 | 0.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.3 | 3.3 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.3 | 0.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 2.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.3 | 0.5 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.3 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.3 | 0.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.3 | 0.8 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 1.7 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.2 | 1.0 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 0.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 5.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 0.7 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.2 | 3.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.2 | 0.5 | GO:0004340 | glucokinase activity(GO:0004340) |
0.2 | 0.7 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 2.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 5.8 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.2 | 0.5 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.2 | 3.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 6.2 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.2 | 0.5 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 0.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 2.9 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.2 | 0.4 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.2 | 0.7 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 3.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 13.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.2 | 2.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 0.7 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 7.4 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.2 | 1.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 3.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 1.0 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.2 | 0.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 32.1 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.2 | 2.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 0.8 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.2 | 5.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 3.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 4.6 | GO:0008144 | drug binding(GO:0008144) |
0.2 | 0.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 1.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 0.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 1.4 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 1.2 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.2 | 3.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.6 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.2 | 1.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 0.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 3.5 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.2 | 0.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 0.4 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.2 | 0.5 | GO:0004556 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.2 | 1.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 0.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 0.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 1.3 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.2 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.2 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.2 | 0.7 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 2.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 0.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 24.8 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.2 | 0.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 22.7 | GO:0016874 | ligase activity(GO:0016874) |
0.2 | 0.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 30.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.2 | 0.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 6.8 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.2 | 0.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 0.6 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.2 | 2.7 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.3 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.2 | 1.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.5 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 1.0 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 0.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.8 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.6 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 1.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.1 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.1 | 0.1 | GO:0004396 | hexokinase activity(GO:0004396) |
0.1 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 1.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 43.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 1.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 8.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 2.8 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 1.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 1.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.3 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 9.7 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.9 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.3 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 1.9 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 0.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 1.6 | GO:0015297 | antiporter activity(GO:0015297) |
0.1 | 0.1 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.7 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 1.8 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.1 | 0.1 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.1 | 1.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 1.3 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 2.0 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) |
0.1 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 2.0 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 1.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 1.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 1.3 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.0 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.0 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 246.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
3.2 | 29.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
3.2 | 53.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
3.1 | 63.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
3.1 | 37.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
2.6 | 104.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
2.6 | 5.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
2.4 | 33.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
2.1 | 48.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.9 | 48.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.9 | 79.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
1.7 | 19.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.6 | 43.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.6 | 41.4 | PID BCR 5PATHWAY | BCR signaling pathway |
1.5 | 18.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.5 | 65.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
1.5 | 22.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.5 | 7.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.5 | 32.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.5 | 2.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.4 | 40.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.3 | 16.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.3 | 17.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.2 | 14.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.1 | 21.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
1.1 | 18.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
1.1 | 12.9 | PID ARF6 PATHWAY | Arf6 signaling events |
1.0 | 19.4 | PID IFNG PATHWAY | IFN-gamma pathway |
1.0 | 7.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.0 | 5.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.0 | 5.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.0 | 17.2 | PID MYC PATHWAY | C-MYC pathway |
0.9 | 10.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.9 | 31.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.9 | 13.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.9 | 32.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.9 | 0.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.8 | 3.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.8 | 0.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.8 | 0.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.8 | 9.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.7 | 8.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.7 | 2.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.7 | 0.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.7 | 2.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.7 | 26.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.7 | 9.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.7 | 4.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.7 | 9.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.7 | 1.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.7 | 0.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.6 | 6.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.6 | 20.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.6 | 8.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.6 | 3.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.6 | 2.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.6 | 8.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.6 | 8.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.6 | 15.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.5 | 10.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.5 | 6.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 0.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.5 | 2.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.5 | 18.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.5 | 6.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.5 | 13.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.5 | 1.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.5 | 10.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.5 | 1.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.5 | 0.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 7.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.4 | 8.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.4 | 14.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 4.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.4 | 2.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 0.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 5.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 15.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 6.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.4 | 3.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.4 | 0.8 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 3.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.4 | 12.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 7.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 1.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.4 | 3.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 1.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 1.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 3.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 2.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 1.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 2.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 4.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.3 | 5.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 0.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 11.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 3.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 3.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 1.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 2.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 1.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 0.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 2.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 10.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 2.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 2.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 2.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 2.2 | PID ATM PATHWAY | ATM pathway |
0.2 | 0.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 0.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 1.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 1.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 2.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 5.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 2.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.5 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 3.5 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.3 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.3 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 2.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.1 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.7 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.3 | PID AURORA B PATHWAY | Aurora B signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.8 | 38.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
5.5 | 21.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
5.0 | 55.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
5.0 | 109.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
3.3 | 35.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
3.2 | 3.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
3.0 | 42.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
2.8 | 56.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
2.6 | 58.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
2.5 | 5.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
2.3 | 59.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
2.0 | 26.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.9 | 57.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
1.9 | 26.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.9 | 13.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
1.8 | 34.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.8 | 26.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
1.7 | 17.4 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
1.6 | 35.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
1.6 | 12.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
1.6 | 82.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.6 | 6.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.5 | 28.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.5 | 59.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
1.4 | 31.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.4 | 6.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.4 | 12.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
1.3 | 5.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
1.3 | 6.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.2 | 3.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.1 | 16.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.1 | 21.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
1.1 | 13.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
1.1 | 4.4 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
1.1 | 4.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.1 | 31.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.1 | 3.3 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
1.1 | 5.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.1 | 5.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
1.1 | 21.1 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
1.0 | 4.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.0 | 13.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.0 | 17.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
1.0 | 16.8 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
1.0 | 1.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
1.0 | 1.9 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
1.0 | 5.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
1.0 | 15.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.9 | 32.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.9 | 10.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.9 | 13.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.9 | 7.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.9 | 3.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.9 | 22.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.8 | 4.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.8 | 39.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.8 | 4.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.8 | 0.8 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.8 | 10.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.8 | 5.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.8 | 6.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.8 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.8 | 6.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.8 | 2.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.8 | 14.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.8 | 8.3 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.8 | 4.5 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.8 | 0.8 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.7 | 3.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.7 | 18.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.7 | 8.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.7 | 2.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.7 | 19.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.7 | 2.9 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.7 | 34.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.7 | 9.7 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.7 | 3.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.7 | 4.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.7 | 1.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.7 | 16.2 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.7 | 10.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.7 | 41.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.7 | 12.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.7 | 4.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.7 | 1.3 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.6 | 4.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.6 | 13.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.6 | 0.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.6 | 5.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.6 | 6.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.6 | 1.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.6 | 10.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.6 | 4.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.6 | 5.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.6 | 5.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.6 | 12.4 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.6 | 1.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.6 | 1.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.6 | 4.6 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.6 | 6.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.6 | 4.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.6 | 16.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.6 | 8.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.6 | 19.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.6 | 63.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.5 | 17.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.5 | 4.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.5 | 7.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 4.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.5 | 8.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 4.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.5 | 22.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 7.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.5 | 9.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.5 | 12.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.5 | 1.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.5 | 6.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 37.5 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.5 | 32.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.5 | 6.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.5 | 4.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.5 | 1.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.5 | 0.9 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.5 | 5.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 17.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.5 | 1.4 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.4 | 1.8 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.4 | 8.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.4 | 13.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.4 | 20.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.4 | 26.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 7.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.4 | 3.3 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex |
0.4 | 28.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 7.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.4 | 8.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.4 | 1.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.4 | 5.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.4 | 2.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 4.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 8.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 4.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.4 | 1.5 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.4 | 3.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 3.7 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 4.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.4 | 4.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.4 | 2.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.4 | 5.4 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.4 | 0.4 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.3 | 0.7 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.3 | 4.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.3 | 6.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 0.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.3 | 0.3 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.3 | 4.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 4.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 4.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 9.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.3 | 2.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 5.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 4.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 20.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 2.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 13.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 2.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 9.4 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.3 | 3.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.3 | 5.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 0.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.3 | 8.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 4.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 3.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.3 | 3.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 3.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 1.6 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.3 | 1.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 4.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 0.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 3.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 4.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 0.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 3.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 11.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 8.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 0.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 0.2 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.2 | 4.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 2.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.2 | 9.1 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 10.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 5.8 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 1.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 0.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 15.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 1.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 2.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 0.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 6.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 2.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 28.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 2.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 36.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 1.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 2.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 3.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 1.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 3.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.3 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 0.8 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 2.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 1.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.4 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.0 | 0.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |